An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)

Clinical Trial Details

SystHERs Registry

An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Breast Cancer
Study Type: Non-interventional
Phase: Phase IV
Study Start Date: 06/12/2012
Study Completion Date: TBD

This multi-center, prospective observational study will evaluate the treatment patterns, and the safety in patients with HER2-positive (HER2+) metastatic breast cancer (MBC). Eligible patients will have an initial metastatic breast cancer diagnosis that has not been previously treated with systemic therapy; patients may be enrolled up to 6 months after the diagnosis. Data will be collected for up to 8 years.

NCT Number
NCT01615068
Principal Investigator(s)
John Wallmark, MD
Sponsor(s)
Genentech, Inc
Participant Eligibility
  • Age: 18 - No Maximum
  • Gender: Male, Female

Location

  • Shady Grove Adventist Aquilino Cancer Center
    9905 Medical Center Drive
    Rockville, MD 20850
    Main: 240-826-6297

Find a Doctor

Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.

View Doctors

Set Your Location

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.